Treatment of congestive heart failure
US5234953A · kind A · utility
68Cited by
6References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 1991 |
| Grant date | Aug 10, 1993 |
| Priority date | — |
| Expiry date | May 23, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is concerned with the use of a compound of formula (I) ##STR1## wherein --W-- is ##STR2## wherein Z is --V(CH.sub.2).sub.b CO.sub.2 H where b is 1 or 2 and V is oxygen when b is 1 or methylene when b is 2; PA1 X is hydrogen, cyano, or --C.tbd.CH; and PA1 the dotted line represents an optional double bond; PA1 and physiologically functional derivatives thereof, PA1 in the treatment of congestive heart failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.